Finger length may hold clues to kidney stone risk
NCT ID NCT07736924
First seen Jul 30, 2026 · Last updated Jul 31, 2026 · Updated 1 time
Summary
This observational study investigates whether the ratio of the second to fourth finger length (2D:4D) is associated with urinary stone disease. Researchers will compare finger measurements between adults with kidney or ureteral stones and stone-free controls, all confirmed by CT scans. The study also examines whether this ratio relates to stone recurrence, burden, or bilaterality.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 300 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Aug 2026
An estimate. Start dates often move.
- Expected to finish
-
Jan 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The study population will consist of consecutive adults undergoing non-contrast computed tomography at Malatya Training and Research Hospital during the study period. Participants with kidney and/or ureteral stones will constitute the case group. Participants without urinary stones on computed tomography and without a previous history of urinary stone disease or stone surgery will constitute the control group.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 18 years or older * Provision of written informed consent * Undergoing non-contrast computed tomography at Malatya Training and Research Hospital during the study period * For cases: presence of at least one kidney and/or ureteral stone on non-contrast computed tomography * For controls: absence of stones in the kidneys, ureters, and bladder on non-contrast computed tomography * For controls: no previous physician-diagnosed urinary stone disease or history of stone-related surgery * Feasibility of bilateral second- and fourth-digit length measurements Exclusion Criteria: * Congenital deformity of the hands or fingers * History of hand or finger trauma, fracture, surgery, or amputation that may affect digit length measurement * Severe hand deformity, contracture, or advanced joint disease preventing reliable measurement * Incomplete, inadequate, or technically unreliable 2D:4D measurements * Missing essential clinical, demographic, or imaging data * Pregnancy * Presence of bladder stones * Urinary diversion, major urinary tract reconstruction, or a significant structural urinary tract anomaly
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Urinary stone are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Malatya Training and Research Hospital
Malatya, Malatya, 44000, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.